Orexin Gene in Anorexia Nervosa

计划入组 60 人 · 首次发布于 2025 年 1 月 30 日

Targeting Orexin to Treat Nicotine Dependence

计划入组 45 人 · 首次发布于 2019 年 6 月 26 日

Plasma Orexin A and mRNA Expression Levels of Pre-pro-orexin Gene in Attention-Deficit Hyperactivity Disorder

计划入组 50 人 · 首次发布于 2014 年 2 月 28 日

orexin 2 receptor agonist (narcolepsy)

Dual Orexin OX1/OX2 Receptor Agonists (Orexia)

OREXIN AGONISTS

MEREO BIOPHARMA 2 LIMITED

United Kingdom

UpJohn US 2 LLC

United States

RIVER 2 RENAL CORP.

United States

Johnson & Johnson Presents Phase 3 Data for Seltorexant in Major Depressive Disorder at 2025 Psych Congress

Eisai's E2086 Receives Orphan Drug Designation in Japan for Narcolepsy Treatment

Johnson & Johnson to Present Phase 3 CAPLYTA Data Across Bipolar Mania, Depression and Schizophrenia at Psych Congress 2026